AORTIC VALVE STENOSIS

This study compares two types of TAVR devices (self-expanding vs. balloon-expandable) in over 1,100 people with severe aortic stenosis and a small aortic annulus. The goal is to see which device leads to fewer deaths, strokes, or hospitalizations, and which performs better over t…

This study compares two procedures for severe aortic valve stenosis: transcatheter aortic valve implantation (TAVI), a less invasive approach, and standard open-heart surgery. It will follow 4,000 high-risk patients for up to 24 months to see which method leads to fewer deaths, h…

This study compares two ways to replace a narrowed heart valve in people with severe aortic stenosis who are at intermediate risk for surgery. About 1,400 participants will be randomly assigned to get either a less invasive TAVI procedure or open-heart surgery (SAVR). The main go…

This study tests whether a less invasive procedure called TAVR (replacing the aortic valve through a tube in an artery) is as safe and effective as open-heart surgery for people with severe aortic stenosis who are otherwise healthy enough for surgery. About 2,200 participants wil…

This study tests a new device called the Navitor TAVI system to replace a stiff, narrowed heart valve without open-heart surgery. It includes 1,500 people with severe aortic stenosis who are at low or intermediate risk for surgery. The goal is to see if the device is safe and eff…

This study is testing a newer version of a heart valve device, called the SAPIEN 3 Ultra, in 200 people with severe aortic stenosis (a narrowed heart valve). The valve is implanted through a tube in an artery, avoiding open-heart surgery. Researchers are checking how well the val…

This study compares two types of TAVI valves (Edwards and CoreValve Evolut) in 102 people with small, failing surgical aortic valves. The goal is to see which valve leads to fewer problems like high pressure or leakage after the procedure. Results could guide doctors in choosing …

This study compares two newer self-expanding heart valves and a minimalist approach (using only local anesthesia, avoiding extra tubes) against standard care for people with severe aortic valve stenosis. About 836 participants will be randomly assigned to receive either the new v…

This trial compares two types of replacement heart valves used in a procedure called TAVI for people with a narrowed aortic valve. One valve expands with a balloon, the other expands on its own. The study will track about 1,960 patients to see which valve leads to fewer deaths or…

This study is testing a new device called the CENTERA THV, which is a replacement heart valve that can be placed without open-heart surgery. It is for people with severe aortic stenosis (a narrowed heart valve) who are at intermediate risk for surgery. The study will monitor safe…

This study was designed to test a device called Leaflex Performer for people with severe aortic stenosis, a condition where the heart's aortic valve becomes narrow. The goal was to see if the device could safely improve valve function without needing surgery or a new valve. Howev…

This study tests whether icosapent ethyl, a purified fish-oil medication, can slow the buildup of calcium in the aortic valve. About 110 adults with mild-to-moderate aortic valve stenosis will take the drug or a placebo. The main goal is to see if the drug reduces the increase in…

This phase 3 trial tests whether colchicine, an anti-inflammatory drug, can slow the progression of aortic valve stenosis—a narrowing of the heart's aortic valve that currently has no drug treatment. The study enrolls 150 people with moderate, symptom-free valve disease. Particip…

This study looks at people with severe aortic stenosis (a narrowed heart valve) who don't yet have symptoms. Doctors usually wait until symptoms appear before replacing the valve, but by then the heart may already be damaged. The researchers use MRI scans to find hidden scarring …

This pilot study tests whether a smartphone app, using its built-in microphone and machine learning, can detect severe aortic stenosis – a common but serious heart valve issue. Researchers will record heart sounds from 100 adults (with and without the condition) and compare the a…

This study looks at how certain blood components and heart imaging patterns might help predict the worsening of aortic stenosis, a common heart valve condition in older adults. Researchers will study 65 people with mild or moderate aortic stenosis and compare them to healthy cont…

This study tests whether wearing a portable heart monitor for up to three months before a TAVI procedure can detect silent arrhythmias in people with severe aortic stenosis. The goal is to see if catching these hidden rhythm issues early can lead to treatments that improve outcom…

This study follows 1000 patients who had a standard aortic valve replacement (TAVR) to see how their heart rhythms change over a year. Researchers will track abnormal heartbeats using ECG monitors. The goal is to learn which patients are at risk for rhythm problems and how they r…

This study is a registry that tracks 900 people with aortic valve stenosis who had either a surgical aortic valve replacement (SAVR) or a transcatheter aortic valve replacement (TAVR). The goal is to compare how safe and effective these two procedures are over time. Researchers a…

This study followed 900 adults who had their aortic valve replaced to see how safe and effective the procedure is in routine care. Researchers tracked deaths from any cause and heart-related deaths. The goal is to understand real-world outcomes beyond controlled trials.

This study looks at 364 people with mild to moderate aortic valve narrowing (aortic stenosis) to see if those with high levels of lipoprotein(a) — a type of fat in the blood — have faster disease progression than those with low levels. Participants are observed over time using he…

This study was designed to measure levels of a protein called SGLT2 in heart muscle samples taken during valve replacement surgery in people with aortic stenosis. Researchers wanted to compare SGLT2 levels between those with and without diastolic heart failure to better understan…

This study looks at whether people who get a new heart valve through a tube in their leg (TAVI) can safely go home just 24 hours later. Researchers will track 585 patients for complications like stroke, heart attack, or need for a pacemaker. The goal is to see if early discharge …